tiprankstipranks
Pds Biotechnology (PDSB)
NASDAQ:PDSB
US Market

PDS Biotechnology (PDSB) Income Statement

818 Followers

PDS Biotechnology Income Statement

Last quarter (Q4 2025), PDS Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, PDS Biotechnology's net income was $-9.90M. See PDS Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -60.52K$ -59.79K$ -57.33K$ 0.00$ 0.00
Operating Expenses
$ 31.54M$ 36.26M$ 43.05M$ 41.67M$ 21.44M
Depreciation and Amortization
$ 21.84K$ 59.79K$ 57.33K$ 86.00$ 5.36K
EBITDA
$ -30.30M$ -33.75M$ -40.09M$ -40.74M$ -21.43M
Operating Income
$ -31.54M$ -36.32M$ -43.05M$ -41.67M$ -21.44M
Other Income/Expenses
$ -4.12M$ -2.16M$ -1.30M$ -381.34K$ 4.35K
Pretax Income
$ -35.67M$ -38.48M$ -44.35M$ -42.05M$ -21.43M
Net Income
$ -36.84M$ -37.61M$ -42.94M$ -40.85M$ -16.92M
Per Share Metrics
Basic EPS
$ -0.74$ -1.03$ -1.39$ -1.43$ -0.66
Diluted EPS
$ -0.74$ -1.03$ -1.39$ -1.43$ -0.66
Weighted Average Shares Outstanding
46.38M 36.45M 30.95M 28.60M 25.60M
Weighted Average Shares Outstanding (Diluted)
46.38M 36.45M 30.95M 28.60M 25.60M
Currency in USD

PDS Biotechnology Earnings and Revenue History